These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12498913)

  • 21. Antidystonic effects of the NMDA receptor antagonists memantine, MK-801 and CGP 37849 in a mutant hamster model of paroxysmal dystonia.
    Richter A; Fredow G; Löscher W
    Neurosci Lett; 1991 Nov; 133(1):57-60. PubMed ID: 1686481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoradiographic and pharmacological studies on the role of dopamine D3 receptors in genetically dystonic (dt(sz)) hamsters.
    Sander SE; Raymond R; Nobrega JN; Richter A
    Pharmacol Biochem Behav; 2010 Aug; 96(2):136-40. PubMed ID: 20451545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spinal cord long-term potentiation is attenuated by the NMDA-2B receptor antagonist Ro 25-6981.
    Pedersen LM; Gjerstad J
    Acta Physiol (Oxf); 2008 Mar; 192(3):421-7. PubMed ID: 17970830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.
    Higgins GA; Ballard TM; Enderlin M; Haman M; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):85-98. PubMed ID: 15759152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson's disease.
    Löschmann PA; De Groote C; Smith L; Wüllner U; Fischer G; Kemp JA; Jenner P; Klockgether T
    Exp Neurol; 2004 May; 187(1):86-93. PubMed ID: 15081591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antinociception and prevention of hyperalgesia by intrathecal administration of Ro 25-6981, a highly selective antagonist of the 2B subunit of N-methyl-D-aspartate receptor.
    Jiang M; Zhang W; Ma Z; Gu X
    Pharmacol Biochem Behav; 2013 Nov; 112():56-63. PubMed ID: 24076088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the kynurenine 3-hydroxylase inhibitor Ro 61-8048 after intrastriatal injections on the severity of dystonia in the dt sz mutant.
    Hamann M; Sander SE; Richter A
    Eur J Pharmacol; 2008 May; 586(1-3):156-9. PubMed ID: 18353306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.
    Fischer G; Mutel V; Trube G; Malherbe P; Kew JN; Mohacsi E; Heitz MP; Kemp JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1285-92. PubMed ID: 9400004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices.
    Mallon AP; Auberson YP; Stone TW
    Exp Brain Res; 2005 Apr; 162(3):374-83. PubMed ID: 15580338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dextrorphan, but not dextromethorphan, exerts weak antidystonic effects in mutant dystonic hamsters.
    Richter A; Löscher W
    Brain Res; 1997 Jan; 745(1-2):336-8. PubMed ID: 9037429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid.
    Fantin M; Morari M; Tison F; Fernagut PO
    Neurol Res; 2011 May; 33(4):444-7. PubMed ID: 21535946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster.
    Hamann M; Sander SE; Kreil A; Richter A
    J Neural Transm (Vienna); 2010 Jun; 117(6):747-57. PubMed ID: 20454986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different action of a specific NR2B/NMDA antagonist Ro 25-6981 on cortical evoked potentials and epileptic afterdischarges in immature rats.
    Szczurowska E; Mareš P
    Brain Res Bull; 2015 Feb; 111():1-8. PubMed ID: 25446739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The carbonic anhydrase inhibitor acetazolamide exerts antidystonic effects in the dt(sz) mutant hamster.
    Richter A; Hamann M
    Eur J Pharmacol; 2004 Oct; 502(1-2):105-8. PubMed ID: 15464095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
    Gogas KR
    Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of interactions of RO 25-6981 with the NR2B (epsilon2) subunit.
    Lynch DR; Shim SS; Seifert KM; Kurapathi S; Mutel V; Gallagher MJ; Guttmann RP
    Eur J Pharmacol; 2001 Mar; 416(3):185-95. PubMed ID: 11290368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of (R)-1-[2-hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: a novel NR1/2B subtype selective NMDA receptor antagonist.
    Pinard E; Alanine A; Bourson A; Büttelmann B; Gill R; Heitz M; Jaeschke G; Mutel V; Trube G; Wyler R
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2173-6. PubMed ID: 11514163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Forelimb dyskinesia mediated by high-frequency stimulation of the subthalamic nucleus is linked to rapid activation of the NR2B subunit of N-methyl-D-aspartate receptors.
    Quintana A; Melon C; Kerkerian-Le Goff L; Salin P; Savasta M; Sgambato-Faure V
    Eur J Neurosci; 2010 Aug; 32(3):423-34. PubMed ID: 20673310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit.
    Chaperon F; Müller W; Auberson YP; Tricklebank MD; Neijt HC
    Behav Pharmacol; 2003 Sep; 14(5-6):477-87. PubMed ID: 14501261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt
    Hamann M; Plank J; Richter F; Bode C; Smiljanic S; Creed M; Nobrega JN; Richter A
    Neuroscience; 2017 Aug; 357():84-98. PubMed ID: 28596119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.